NO20030420L - Medikament for immunoterapi av maligne tumorer - Google Patents
Medikament for immunoterapi av maligne tumorerInfo
- Publication number
- NO20030420L NO20030420L NO20030420A NO20030420A NO20030420L NO 20030420 L NO20030420 L NO 20030420L NO 20030420 A NO20030420 A NO 20030420A NO 20030420 A NO20030420 A NO 20030420A NO 20030420 L NO20030420 L NO 20030420L
- Authority
- NO
- Norway
- Prior art keywords
- immunotherapy
- medication
- malignant tumors
- tumors
- medicament
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 4
- 238000009169 immunotherapy Methods 0.000 title abstract 3
- 201000011510 cancer Diseases 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 4
- 238000002255 vaccination Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4615—Dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4622—Antigen presenting cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/02—Compounds of the arachidonic acid pathway, e.g. prostaglandins, leukotrienes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/24—Interferons [IFN]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/25—Tumour necrosing factors [TNF]
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00116362 | 2000-07-28 | ||
| PCT/EP2001/008455 WO2002009745A1 (de) | 2000-07-28 | 2001-07-21 | Arzneimittel zur immuntherapie maligner tumoren |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20030420D0 NO20030420D0 (no) | 2003-01-27 |
| NO20030420L true NO20030420L (no) | 2003-01-27 |
Family
ID=8169380
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20030420A NO20030420L (no) | 2000-07-28 | 2003-01-27 | Medikament for immunoterapi av maligne tumorer |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US20030129206A1 (pt) |
| EP (1) | EP1305041B1 (pt) |
| JP (1) | JP2004505058A (pt) |
| AT (1) | ATE330626T1 (pt) |
| AU (1) | AU2001279775A1 (pt) |
| BG (1) | BG107482A (pt) |
| CA (1) | CA2417374A1 (pt) |
| CY (1) | CY1105179T1 (pt) |
| CZ (1) | CZ299669B6 (pt) |
| DE (1) | DE50110274D1 (pt) |
| DK (1) | DK1305041T3 (pt) |
| ES (1) | ES2267800T3 (pt) |
| HK (1) | HK1055562A1 (pt) |
| HU (1) | HUP0300772A3 (pt) |
| NO (1) | NO20030420L (pt) |
| PL (1) | PL358675A1 (pt) |
| PT (1) | PT1305041E (pt) |
| SI (1) | SI1305041T1 (pt) |
| SK (1) | SK822003A3 (pt) |
| WO (1) | WO2002009745A1 (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030211971A1 (en) * | 2001-09-17 | 2003-11-13 | Srivastava Pramod K. | Compositions and methods for prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with compositions comprising unfractionated cellular proteins |
| JP2006514088A (ja) * | 2003-02-20 | 2006-04-27 | ユニバーシティー オブ コネティカット ヘルス センター | 癌および感染症の治療における熱ショックタンパク質またはα−２−マクログロブリンを含む組成物の使用方法 |
| US7674456B2 (en) * | 2004-06-14 | 2010-03-09 | Charles Wiseman | Breast cancer cell lines and uses thereof |
| MY160857A (en) | 2006-02-03 | 2017-03-31 | Malaysian Palm Oil Board | A cancer vaccine |
| EP1974742A1 (en) * | 2007-03-29 | 2008-10-01 | LipoNova AG | A method for improving the manufacturing process of a tumour vaccine |
| MX2011013452A (es) | 2009-07-02 | 2012-04-30 | Ith Immune Therapy Holdings Ab | Tratamiento de cancer basado en exosomas. |
| CN105807053B (zh) | 2016-04-15 | 2019-04-02 | 苏州药明康德新药开发股份有限公司 | 一种肿瘤解离试剂在流式细胞检测中的应用 |
| EP3425400B1 (en) | 2017-07-05 | 2022-01-26 | VCC Medical Deutschland GmbH | Method for manufacturing a tumor vaccine |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6077519A (en) * | 1993-01-29 | 2000-06-20 | University Of Pittsburgh | Methods for isolation and use of T cell epitopes eluted from viable cells in vaccines for treating cancer patients |
| DE19633731A1 (de) * | 1996-08-21 | 1998-02-26 | Johann Hinrich Prof Dr Peters | Hybridzellen zur Steigerung der Immunogenität von Tumorzellen |
| AU2872199A (en) * | 1998-02-20 | 1999-09-06 | Rockefeller University, The | Apoptotic cell-mediated antigen presentation to dendritic cells |
| DE19812004A1 (de) * | 1998-03-19 | 1999-09-30 | Forschungszentrum Juelich Gmbh | Dehydrogenasen mit verbesserter NAD-Abhängigkeit, deren Herstellung und Verwendung |
| JP2002506886A (ja) * | 1998-03-20 | 2002-03-05 | ジェンザイム・コーポレーション | 抗腫瘍免疫亢進 |
| CA2326739A1 (en) * | 1998-04-02 | 1999-10-14 | The Regents Of The University Of California | Methods for enhancing antigen-presenting cells and anti-tumor responses in a human patient |
| US6045990A (en) * | 1998-07-09 | 2000-04-04 | Baust; John M. | Inclusion of apoptotic regulators in solutions for cell storage at low temperature |
-
2001
- 2001-07-21 HU HU0300772A patent/HUP0300772A3/hu unknown
- 2001-07-21 US US09/926,630 patent/US20030129206A1/en not_active Abandoned
- 2001-07-21 PT PT01958002T patent/PT1305041E/pt unknown
- 2001-07-21 AU AU2001279775A patent/AU2001279775A1/en not_active Abandoned
- 2001-07-21 EP EP01958002A patent/EP1305041B1/de not_active Expired - Lifetime
- 2001-07-21 SK SK82-2003A patent/SK822003A3/sk unknown
- 2001-07-21 SI SI200130618T patent/SI1305041T1/sl unknown
- 2001-07-21 CA CA002417374A patent/CA2417374A1/en not_active Abandoned
- 2001-07-21 CZ CZ20030179A patent/CZ299669B6/cs not_active IP Right Cessation
- 2001-07-21 JP JP2002515298A patent/JP2004505058A/ja not_active Abandoned
- 2001-07-21 DK DK01958002T patent/DK1305041T3/da active
- 2001-07-21 WO PCT/EP2001/008455 patent/WO2002009745A1/de active IP Right Grant
- 2001-07-21 PL PL01358675A patent/PL358675A1/xx unknown
- 2001-07-21 DE DE50110274T patent/DE50110274D1/de not_active Expired - Fee Related
- 2001-07-21 AT AT01958002T patent/ATE330626T1/de not_active IP Right Cessation
- 2001-07-21 ES ES01958002T patent/ES2267800T3/es not_active Expired - Lifetime
-
2003
- 2003-01-21 BG BG107482A patent/BG107482A/bg active Pending
- 2003-01-27 NO NO20030420A patent/NO20030420L/no not_active Application Discontinuation
- 2003-10-27 HK HK03107742A patent/HK1055562A1/xx not_active IP Right Cessation
-
2006
- 2006-08-29 CY CY20061101216T patent/CY1105179T1/el unknown
- 2006-11-06 US US11/593,132 patent/US20070134275A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0300772A2 (en) | 2003-08-28 |
| ATE330626T1 (de) | 2006-07-15 |
| WO2002009745A1 (de) | 2002-02-07 |
| ES2267800T3 (es) | 2007-03-16 |
| DK1305041T3 (da) | 2006-10-23 |
| SI1305041T1 (sl) | 2006-12-31 |
| SK822003A3 (en) | 2004-05-04 |
| HUP0300772A3 (en) | 2005-11-28 |
| US20070134275A1 (en) | 2007-06-14 |
| NO20030420D0 (no) | 2003-01-27 |
| HK1055562A1 (en) | 2004-01-16 |
| PL358675A1 (en) | 2004-08-09 |
| EP1305041A1 (de) | 2003-05-02 |
| JP2004505058A (ja) | 2004-02-19 |
| AU2001279775A1 (en) | 2002-02-13 |
| BG107482A (bg) | 2003-11-28 |
| US20030129206A1 (en) | 2003-07-10 |
| CY1105179T1 (el) | 2010-03-03 |
| CA2417374A1 (en) | 2003-01-27 |
| PT1305041E (pt) | 2006-09-29 |
| CZ2003179A3 (cs) | 2004-01-14 |
| DE50110274D1 (de) | 2006-08-03 |
| EP1305041B1 (de) | 2006-06-21 |
| CZ299669B6 (cs) | 2008-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU23202A (sh) | Lekovi za tretman malignih tumora | |
| NO20021932D0 (no) | Medikament egnet til behandling av ondartede tumorer | |
| EA200101046A1 (ru) | Производные индигоидных бис-индолов | |
| SE9901875D0 (sv) | Novel compounds | |
| DK1519724T3 (da) | Fredericamycin-derivater som lægemidler til behandling af tumorer | |
| BRPI0207961A8 (pt) | Uso de análogos de epotilona e capecitabina para fabricar medicamento para tratar tumores cancerosos sólidos e kit compreendendo os referidos compostos. | |
| AU2001233726A1 (en) | Farnesyl protein transferase inhibitors for treating breast cancer | |
| MY128924A (en) | Novel compounds | |
| IL153680A0 (en) | Aplidine derivatives and methods for the preparation thereof | |
| CY1105179T1 (el) | Φαρμακα για την ανοσοθepαπεια κακοηθων ογκων | |
| YU68702A (sh) | Novi lhrh-antagonisti, njihova proizvodnja i upotreba kao leka | |
| HUP0105281A2 (hu) | Rákellenes hatású benzaldehidszármazékok és gyógyászati alkalmazásuk | |
| BR0015597A (pt) | Uso de anticorpos como vacinas | |
| DE60123117D1 (de) | Verwendung von alpha-halogenacryloyl-distamycin derivaten zur herstellung eines medikaments zur behandlung von krebs | |
| JP2017529386A5 (pt) | ||
| TW200504051A (en) | Novel acridine derivatives and their use as medicaments | |
| BR0008307A (pt) | Utilização de uma proteìna ompa de enterobactéria ou de um de seus fragmentos, e, composição farmacêutica | |
| MY127819A (en) | Optically pure camptothecin analogues | |
| UA87292C2 (ru) | Применение сирамезина для лечения злокачественных опухолей | |
| DE60235085D1 (de) | Herstellungsverfahren von derivate von bisphosphonaten | |
| EA200600987A1 (ru) | Применение сирамезина в лечении злокачественных опухолей | |
| ECSP003491A (es) | Nuevas indolinonas sustituidas, su preparacion y su empleo como medicamentos | |
| UY26180A1 (es) | Nuevas indolinonas sustituidas, su preparación y su empleo como medicamentos | |
| MXPA05003633A (es) | 2"-oxo-voruscharina y derivados de la misma. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |